التداخل بين ترانيلسيبرومين وفينلافاكسين
ترانيلسيبرومين وفينلافاكسين: كلتا نشرتَي الوصف تنبّهان إلى هذا الجمع بأشد العبارات، مثل مانع استعمال أو تحذير مؤطر أو تعليمات بتجنّبه.
لا تجمع بينهما دون توجيه من الطبيب الواصف. عبارات النشرة الواردة أدناه هي أشد ما تستخدمه FDA.
ما تقوله نشرات FDA
من نشرة فينلافاكسين (Venlafaxine Hydrochloride) · تاريخ السريان 2025-01-31
Anyone considering the use of Venlafaxine Extended Release Tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.
Serotonin Syndrome and MAOIs: Do not use MAOI’s intended to treat psychiatric disorders with Venlafaxine Extended Release Tablets or within 7 days of stopping treatment with Venlafaxine Extended Release Tablets.
Do not use Venlafaxine Extended Release Tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders.
Monoamine Oxidase Inhibitors (MAOIs) The use of MAOI’s intended to treat psychiatric disorders with Venlafaxine Extended Release Tablets or within 7 days of stopping treatment with Venlafaxine Extended Release Tablets is contraindicated because of an increased risk of serotonin syndrome.
The use of Venlafaxine Extended Release Tablets within 14 days of stopping, an MAOI intended to treat psychiatric disorders is also contraindicated [see Dosage and Administration ( 2.6 ), and Warnings and Precautions ( 5.2 )] .
من نشرة ترانيلسيبرومين (Tranylcypromine Sulfate) · تاريخ السريان 2025-07-25
…sulfate tablets if you: take certain medicines, including: antidepressants, such as: other monoamine oxidase inhibitors (MAOIs) selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) tricyclic antidepressants other antidepressants, such as amoxapine, bupropion, maprotiline, nefazodone, trazodone, vilazodone,…
Concomitant use or use in rapid succession with other MAOIs; selective serotonin reuptake inhibitors; serotonin and norepinephrine reuptake inhibitors; tricyclic antidepressants; sympathomimetic drugs; and numerous other drugs.
…Non-selective H1 receptor antagonists Antidepressants including but not limited to: Other monoamine oxidase inhibitors (MAOIs) Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) Tricyclic antidepressants Other antidepressants (e.g., amoxapine, bupropion, maprotiline, nefazodone, trazodone, vilazodone,…
Serotonin Syndrome The development of a potentially life-threatening serotonin syndrome has been reported with MAOIs when used concomitantly with other serotonergic drugs.
The concomitant use, or use in rapid succession, of tranylcypromine sulfate tablets with other serotonergic drugs is contraindicated.
هل تتناول أكثر من هذين الاثنين؟ التداخلات تتراكم. افحص قائمتك كاملة دفعة واحدة؛ وهي تبقى في متصفحك.
افتح في الفاحصليست نصيحة طبية. يقتبس Interaction Checker نص نشرات FDA وصحائف الوقائع الصادرة عن NIH. وأهمية التداخل في حالتك تتوقف على الجرعات والتوقيت ووظائف الكلى والكبد والحالات الصحية الأخرى. تأكّد من ذلك مع صيدلي أو مع الطبيب الواصف.